comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 09:46:31 - browse：9

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： CVS Caremark has created a new ploy: the drug ‘rebate credit’

WSS

House looks to weaken Medicare negotiation

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

UnitedHealth increases loan offers after Change Healthcare outage

Pfizer highlights cancer drugs it thinks could reignite investor interest

U.K. researchers warn about biases in medical devices, algorithms

House looks to weaken Medicare negotiation

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Covid isolation guidance eased by the CDC

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Plastic surgeons increase patient psychiatric screenings

Malaria cases in Florida and Texas: Here’s what you need to know

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Baby aspirin cuts fat buildup in liver disease patients, in small study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

RSV vaccines may be linked to small increased risk of developing GBS

focus

Health AI adoption puts security, privacy startups on investors' radar

International team creates first chimeric human

Asbestos, a deadly carcinogen, banned by EPA

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Intermittent fasting comes with a heart risk? Not so fast

A Q&A with Aletha Maybank, AMA’s chief health equity officer

leisure time

leisure time

hotspot

knowledge